Great News!
At San Antonio (Annual Breast Cancer Symposium in early Dec., for those who don't know what this is when we mention "San antonio") I visited a booth in the Exhibition Area. The sign said ABRAXIS.
There were fresh printouts of the "poster session" (this term means a report of data or studies presented at the symposium by researchers). I asked the woman if this had anything to do with "Abraxane." The drug talked about in the poster was by some letter/number name.
She told me that she was not allowed to mention the commercial name of the drug, but since I had brought it up, would talk about it! No one else was near to hear us.
She told me that the drug would very likely get the approval in Jan. and be out with a few short months fairly widely. I told her that my med onc had talked to me about it as a drug he would like to use if necessary in the future since all the Taxol I took had destroyed my deep tendon reflexes, and this one was supposed to be much more gentle in this respect.
She was also glad to meet someone from the patient side of things and get a peek into the clinical angle.
